RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin

被引:23
作者
Janardhanan, Pavithra [1 ,2 ]
Mello, Charlene M. [1 ,2 ,3 ]
Singh, Bal Ram [1 ,2 ]
Lou, Jianlong [4 ]
Marks, James D. [4 ]
Cai, Shuowei [1 ,2 ]
机构
[1] Univ Massachusetts Dartmouth, Botulinum Res Ctr, N Dartmouth, MA 02747 USA
[2] Univ Massachusetts Dartmouth, Dept Chem & Biochem, N Dartmouth, MA 02747 USA
[3] US Army Natick Soldier Res Dev & Engn Ctr NSRDEC, Biosci & Technol Team, Natick, MA 01760 USA
[4] Univ Calif San Francisco, Dept Anesthesia & Pharmaceut Chem, San Francisco, CA 94110 USA
关键词
RNA aptamer; Botulinum neurotoxin; Surface Plasmon Resonance; Aptasensor; IN-VITRO SELECTION; TOXIN TYPE-A; FOOD; EVOLUTION; APTAMERS; ASSAY;
D O I
10.1016/j.talanta.2013.09.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A surface plasmon resonance based RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin is reported. Using detoxified recombinant type A botulinum neurotoxin as the surrogate, the aptasensor detects active toxin within 90 min. The detection limit of the aptasensor in phosphate buffered saline, carrot juice, and fat free milk is 5.8 ng/ml, 20.3 ng/ml and 23.4 ng/ml, respectively, while that in 5-fold diluted human serum is 22.5 ng/ml. Recovery of toxin from disparate sample matrices are within 91-116%. Most significant is the ability of this aptasensor to effectively differentiate the natively folded toxin from denatured, inactive toxin, which is important for homeland security surveillance and threat assessment. The aptasensor is stable for more than 30 days and over 400 injections/regeneration cycles. Such an aptasensor holds great promise for rapid detection of active botulinum neurotoxin for field surveillance due to its robustness, stability and reusability. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 35 条
  • [1] Botulinum toxin as a biological weapon - Medical and public health management
    Arnon, SS
    Schechter, R
    Inglesby, TV
    Henderson, DA
    Bartlett, JG
    Ascher, MS
    Eitzen, E
    Fine, AD
    Hauer, J
    Layton, M
    Lillibridge, S
    Osterholm, MT
    O'Toole, T
    Parker, G
    Perl, TM
    Russell, PK
    Swerdlow, DL
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08): : 1059 - 1070
  • [2] Attomolar Detection of Botulinum Toxin Type A in Complex Biological Matrices
    Bagramyan, Karine
    Barash, Jason R.
    Arnon, Stephen S.
    Kalkum, Markus
    [J]. PLOS ONE, 2008, 3 (04):
  • [3] Aptamer-facilitated biomarker discovery (AptaBiD)
    Berezovski, Maxim V.
    Lechmann, Matthias
    Musheev, Michael U.
    Mak, Tak W.
    Krylov, Sergey N.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (28) : 9137 - 9143
  • [4] C.D.C, 1979, HDB EP CLIN LAB WORK
  • [5] A correlation between differential structural features and the degree of endopeptidase activity of type A botulinum neurotoxin in aqueous solution
    Cai, SW
    Singh, BR
    [J]. BIOCHEMISTRY, 2001, 40 (15) : 4693 - 4702
  • [6] CDC, 1998, Botulism in the United States, 1899-1996 Handbook for Epidemiologists, Clinicians, and Laboratory Workers
  • [7] Centers for Disease Control and Prevention, 2011, NAT BOT SURV
  • [8] In vitro selection of RNA aptamers that inhibit the activity of type A botulinum neurotoxin
    Chang, Tzuu-Wang
    Blank, Michael
    Janardhanan, Pavithra
    Singh, Bal Ram
    Mello, Charlene
    Blind, Michael
    Cai, Shuowei
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (04) : 854 - 860
  • [9] INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS
    ELLINGTON, AD
    SZOSTAK, JW
    [J]. NATURE, 1990, 346 (6287) : 818 - 822
  • [10] An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin
    Evans, E. R.
    Skipper, P. J. A.
    Shone, C. C.
    [J]. JOURNAL OF APPLIED MICROBIOLOGY, 2009, 107 (04) : 1384 - 1391